EP3536334
Krabbameinsbólefni sem beinast gegn stofnfrumukrabbameini
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
15.5.2013EP published:
23.6.2021EP application number:
18213178.9
EP translation filed:
21.9.2021Grant published:
15.10.2021EPO information:
European Patent Register
Max expiry date:
14.5.2033Expiry date:
14.5.2026Next due date:
31.5.2026
Title:
CANCER STEM CELL TARGETED CANCER VACCINES
Timeline
Today
15.5.2013EP application
23.6.2021EP Publication
21.9.2021Translation submitted
15.10.2021Registration published
14.5.2026Expires
Owner
Name:
Stemline Therapeutics Inc.Address:
750 Lexington Avenue, 11th Floor, New York, NY 10022, US
Inventor
Name:
CIRRITO, Thomas, P.Address:
Long Island City, NY New York 11109, US
Name:
BERGSTEIN, IvanAddress:
New York, NY New York 10022, US
Name:
BROOKS, ChristopherAddress:
New York, NY New York 10022, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261647615 PDate:
16.5.2012Country:
US
Classification
Categories:
A61K 38/00
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 5.4.2022
Expires: 14.5.2023
Payer: Árnason Faktor ehf.
Number: 11
Paid: 12.4.2023
Expires: 14.5.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 5.4.2024
Expires: 14.5.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 5.5.2025
Expires: 14.5.2026
Payer: Árnason Faktor ehf.